Microbiological and physicochemical stability of oxycodone hydrochloride solutions for patient-controlled delivery systems

Journal of Pain and Symptom Management

Volumn 40, Issue 1, 2010, Pages 87-94

  Amri, Ahmed ^a   Achour, Ahmed Ben ^a   Chachaty, Elisabeth ^a   Mercier, Lionel ^a   Bourget, Philippe ^a   Paci, Angelo ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Analgesics; Clinical pharmacy; Microbiological stability; Opioids; Oxycodone; Patient controlled delivery system; Physicochemical stability; Quality assurance

Indexed keywords

GLUCOSE; OXYCODONE; SODIUM CHLORIDE; NARCOTIC ANALGESIC AGENT; SOLUTION AND SOLUBILITY;

ANTIMICROBIAL ACTIVITY; ARTICLE; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG STERILITY; DRUG STORAGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; OSMOLALITY; PATIENT CONTROLLED ANALGESIA; PH MEASUREMENT; PHYSICAL CHEMISTRY; ROOM TEMPERATURE; BACTERIA; CALIBRATION; CHEMISTRY; DRUG CONTAMINATION; FUNGUS; INSTRUMENT STERILIZATION; SOLUTION AND SOLUBILITY;

ANALGESIA, PATIENT-CONTROLLED; ANALGESICS, OPIOID; BACTERIA; CALIBRATION; DRUG CONTAMINATION; DRUG DELIVERY SYSTEMS; DRUG STABILITY; FUNGI; OXYCODONE; PHARMACEUTICAL SOLUTIONS; STERILIZATION;

EID: 77955335669     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2009.11.323     Document Type: Article

References (28)

1. World Health Organization Cancer pain relief and palliative care in children 1998 World Health Organization Geneva, Switzerland
2. W.H. Forrest Jr., P.W. Smethurst, and M.E. Kienitz Self-administration of intravenous analgesics Anesthesiology 33 1970 363 365
3. G. Swanson, J. Smith, R. Bulich, P. New, and R. Shiffman Patient-controlled analgesia for chronic cancer pain in the ambulatory setting: a report of 117 patients J Clin Oncol 7 1989 1903 1908
4. S.C. Harvey, C.P. Toussaint, and S.E. Coe Stability of meperidine in an implantable infusion pump using capillary gas chromatography-mass spectrometry and a deuterated internal standard J Pharm Biomed Anal 21 1999 577 583
5. R.H. Enting, W.H. Oldenmenger, and C.C. van der Rijt A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids Cancer 94 2002 3049 3056
6. S. Chapalain-Pargade, I. Laville, and A. Paci Microbiological and physicochemical stability of fentanyl and sufentanil solutions for patient-controlled delivery systems J Pain Symptom Manage 32 2006 90 97
7. S. Grond, D. Zech, and K.A. Lehmann Transdermal fentanyl in the long-term treatment of cancer pain: a prospective study of 50 patients with advanced cancer of the gastrointestinal tract or the head and neck region Pain 69 1997 191 198
8. J.D. Tobias, and D.K. Baker Patient-controlled analgesia with fentanyl in children Clin Pediatr (Phila) 31 1992 177 179
9. E.M. McGrady, A.M. Malinow, D.A. Paly, and B.K. Mokriski Metastatic pain in the parturient: treatment with patient-controlled epidural sufentanil Acta Anaesthesiol Scand 37 1993 594 596
10. E. Kalso, R. Poyhia, and P. Onnela Intravenous morphine and oxycodone for pain after abdominal surgery Acta Anaesthesiol Scand 35 1991 642 646
11. K.P. Leow, M.T. Smith, B. William, and T. Cramond Single dose and steady state pharmacokinetics of oxycodone in patients with cancer Clin Pharmacol Ther 52 1992 487 495
12. P.R. Gardiner Compatibility of an injectable oxycodone formulation with typical diluents, syringes, tubings, infusion bags and drugs for potential co-administration Hosp Pharmacist 10 2003 354 361
13. Haute Autorité de Santé, Commission de la Transparence. Oxynorm 10 mg/ml, solution injectable, Laboratoire Mundipharma, September 7, 2005 and Oxynorm 50 mg/ml, solution injectable, Laboratoire Mundipharma, October 29, 2008.
14. International Narcotics Control Board World requirements of narcotic drugs for 2008, statistics for 2006 2008 United Nations New York
15. T. Binoche, and C. Martineau Practical guide of pain treatments 2nd ed 2005 Elsevier Masson Paris, France 53
16. A. Vermeire, and J.P. Remon Stability and compatibility of morphine Int J Pharm 187 1999 17 51
17. M.D. Le Hoang, C. Sarbach, and P. Prognon Stability of morphine hydrochloride solutions in portable single-use PCA systems. Additives leaching into the morphine solutions J Pharm Clin 17 1998 35 39
18. S.R. Kowalski, and G.K. Gourlay Stability of fentanyl citrate in glass and plastic containers and in a patient-controlled delivery system Am J Hosp Pharm 47 1990 1584 1587
19. G.M. Peterson, K.A. Miller, J.G. Galloway, and P.F. Dunne Compatibility and stability of fentanyl admixtures in polypropylene syringes J Clin Pharm Ther 23 1998 67 72
20. P.J. Roos, J.H. Glerum, and J.W. Meilink Stability of sufentanil citrate in a portable pump reservoir, a glass container and a polyethylene container Pharm Weekbl Sci 14 1992 196 200
21. K. Turnbull, M. Bielech, E. Scott, and S. Law Stability of oxycodone hydrochloride for injection in dextrose and saline solution Can J Hosp Pharm 55 2002 272 277
22. European Directorate for the Quality of Medicines and HealthCare - Council of Europe General methods. 2.6 Biological methods. 2.6.1 Sterility 01/2005:20601 European pharmacopoeia 5th ed 2005 EDQM Strasbourg, France 153 157
23. International Conference of Harmonization. Validation of analytical procedures: methodology ICH (Q2B) (CPMP/ICH/281/95) (1996). Available from www.emea.europa.eu/pdfs/human/ich/028195en.pdf.
24. International Conference of Harmonization. Validation of analytical procedures: Terminology and definition ICH (Q2A) (CPMP/ICH/381/95) (1994). Available from www.emea.europa.eu/pdfs/human/ich/028195en.pdf.
25. U.S. Pharmacopeia Validation of compendial methods 2002 USP Rockville, MD
26. L.A. Trissel, and K.P. Flora Stability studies: Five years later Am J Hosp Pharm 45 1988 1569 1571
27. L.J. Ohlsson, T.S. Rydberg, T. Eden, B.A. Glimhall, and L.A. Thulin Microbiologic and economic evaluation of multiday infusion pumps for control of cancer pain Ann Pharmacother 29 1995 972 976
28. M.C. Nahata, R.S. Morosco, and T.F. Hipple Stability of morphine sulfate in bacteriostatic 0.9% sodium chloride injection stored in glass vials at two temperatures Am J Hosp Pharm 49 1992 2785 2786